Decrease in particle-induced osteolysis in ovariectomized mice

Journal of Orthopaedic Research

Volumn 28, Issue 2, 2010, Pages 178-183

  Nich, Christophe ^a   Marchadier, Arnaud ^b   Sedel, Laurent ^a   Petite, Hervé ^a   Vidal, Catherine ^c   Hamadouche, Moussa ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Useful Progress   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

3D micro CT; Aseptic loosening; Ovariectomy; Particle induced osteolysis; Postmenopausal osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; POLYETHYLENE DERIVATIVE; TARTARIC ACID;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE REMODELING; CALVARIA; CONTROLLED STUDY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PARTICULATE MATTER; PRIORITY JOURNAL; SKULL; STAINING;

ANIMALS; ARTHROPLASTY, REPLACEMENT; BONE REMODELING; DISEASE MODELS, ANIMAL; FEMALE; FRACTURES, BONE; HUMANS; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOLYSIS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PARTICULATE MATTER; POLYETHYLENE; PROSTHESIS DESIGN; PROSTHESIS FAILURE; SKULL;

EID: 73849143879     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20987     Document Type: Article

References (35)

1. Goodman SB, Fornasier VL, Lee J, et al. 1990. The histological effects of the implantation of different sizes of polyethylene particles in the rabbit tibia. J Biomed Mater Res 24:517-524.
2. Willert HG, Bertram H, Buchhorn GH. 1990. Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res 258:95-107.
3. Korovessis P, Repanti M. 1994. Evolution of aggressive granulomatous periprosthetic lesions in cemented hip arthroplasties. Clin Orthop Relat Res 300:155-161.
4. Green TR, Fisher J, Stone M, et al. 1998. Polyethylene particles of a critical size are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 19:2297-2302.
5. Kim KJ, Rubash H, Wilson SC, et al. 1993. A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop Relat Res 287:142-152.
6. Chiba J, Rubash H, Kim KJ, et al. 1994. The characterisation of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop Relat Res 300:304-312.
7. Sabokbar A, Rushton N. 1995. Role of inammatory mediators and adhesion molecules in the pathogenesis of aseptic loosening in total hip arthroplasties. J Arthroplasty 10:810-815.
8. Xu JW, Kotinnen YT, Lassus J, et al. 1996. Tumor necrosis factor-alpha (TNF-α) in loosening of total hip replacement (THR). Clin Exp Rheumatol 14:643-648.
9. Nakagawa N, Kinosaki M, Yamaguchi K, et al. 1998. RANK is the essential signaling receptor for osteoclast differentiating factor in osteoclastogenesis. Biochem Biophys Res Commun 253:395-400.
10. Burgess TL, Qian Y, Kaufman S, et al. 1999. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 145:527-538.
11. Schwarz EM, Lu AP, Goater JJ, et al. 2000. Tumor necrosis factor-alpha l nuclear transcription factor-kappab signaling in periprosthetic osteolysis. J Orthop Res 18:472-480.
12. Ise K, Kawanabe K, Matsusaki T, et al. 2007. Patient sensitivity to polyethylene particles with cemented total hip arthroplasty. J Arthroplasty 22:966-973.
13. von Knoch M, Jewison DE, Sibonga JD, et al. 2004. Decrease in particle-induced osteolysis in obese (ob/ob) mice. Biomaterials 25:4675-4681.
14. Zhang C, Tang T, Ren W, et al. 2008. Influence of mouse genetic background on wear particle-induced in vivo inflammatory osteolysis. Inflamm Res 57:211-215.
15. Riggs BL, Khosla S, Melton LJ. 1998. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13: 763-773.
16. Bertolini DR, Nedwin GE, Bringman TS, et al. 1986. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319:516-518.
17. Lerner UH. 2006. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 85:596-607.
18. Wronski TJ, Dann LM, Scott KS, et al. 1989. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45:360-366.
19. Manolagas SC, Jilka RL. 1995. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311.
20. Libouban H, Moreau MF, Baslé MF, et al. 2003. Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone 33:283-292.
21. Passeri G, Girasole G, Jilka RL, et al. 1993. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133:822-828.
22. von Knoch M, Jewison DE, Sibonga JD, et al. 2004. The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo. J Orthop Res 22:237-243.
23. ASTM Standard F1877-98. 2003. Standard practice for characterization of particles. West Conshohocken, PA: ASTM International.
24. Ragab AA, Van De Motter R, Lavish SA, et al. 1999. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 17:803-809.
25. Müller R, van Campenhout H, van Damme B, et al. 1998. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and microcomputed tomography. Bone 23:59-66.
26. Ragab AA, Nalepka JL, Bi Y, et al. 2002. Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am J Physiol Cell Physiol 283:679-687.
27. Sato T, Shibata T, Ikeda K, et al. 2001. Generation of boneresorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 16:2215-2221.
28. Katavić V, Grcević D, Lee SK, et al. 2003. The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors. Bone 32:581-590.
29. Kimble RB, Srivastava S, Ross FP, et al. 1996. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colonystimulating factor production. J Biol Chem 271:28890-28897.
30. Weitzmann MN, Cenci S, Rifas L, et al. 2000. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 96: 1873-1878.
31. Eghbali-Fatourechi G, Khosla S, Sanyal A, et al. 2003. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221-1230.
32. Sato T, Watanabe K, Masuhara M, et al. 2007. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. J Bone Miner Metab 25:19-27.
33. Nakamura T, Imai Y, Matsumoto T, et al. 2007. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130:811-823.
34. Sechriest VF II, Kyle RF, Marek DJ, et al. 2007. Activity level in young patients with primary total hip arthroplasty: a 5-year minimum follow-up. J Arthroplasty 22:39-47.
35. Takata S, Takao S, Yoshida S, et al. 2008. Therapeutic effects of one-year alendronate treatment in three cases of osteoporosis with parietal thinning of skull. J Med Invest 55:297-302.